Biotechnology is so beaten down, relative valuation metrics suggest some stocks could more than double.
MarketWatch.com - Top Stories, MarketWatch
Sun, 02/06/2022 - 2:53pm
Biotechnology is so beaten down, relative valuation metrics suggest some stocks could more than double.